Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
JAK inhibitors are typically used to suppress the immune system but have also been shown to enhance antitumour and antiviral immune responses. In this Perspective, Zak and Teijaro explore the basis of the immune-enhancing properties of JAK inhibitors and consider whether we can exploit these properties for cancer therapy.
